High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
Rong Fan(Nanfang Hospital), Jinlin Hou(Nanfang Hospital), Yanyan Yu(Novartis (Switzerland)), Jian Sun(Nanfang Hospital), Nikolai V. Naoumov(Peking University), Huiying Rao(Peking University), Xiaoguang Dou(China Medical University), Xieer Liang(Nanfang Hospital), Qing Xie(Shanghai Jiao Tong University), Hongbo Gao(Guizhou University), Yali Liu(Capital Medical University), Yongfeng Yang(Capital Medical University), Qi Xia(Peking University), Yang Song(Qingdao University), Aimin Sun(Zhengzhou University), Hong Ma(Beijing Friendship Hospital), Xueru Yin(Nanfang Hospital), Yongfang Jiang(Central South University), Siru Zhao(Nanfang Hospital), Jia Shang(Henan Provincial People's Hospital), Jianping Xie(Central South University), Junqi Niu(First Hospital of Jilin University)
Cited by 22
Related Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
|Journal of Clinical and Translational Hepatology|2017|277
VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19
|New England Journal of Medicine|2022|227